← Leaderboards
Ian Fleming
Guild Associates, Inc.
$2,889,719
Attributed
$2,889,719
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2019–21$2M$1.5M$1M$500K$0
'19
'20
'21
Funding mix
By agency
NIH$2,889,719 · 3
By mechanism
R01$2,371,822 · 1
N43$299,999 · 1
R21$217,898 · 1
Top collaborators
No co-investigators on record.
Most similar at Guild Associates, Inc.
Same institution · by research overlap
- Natasha Jayna Sharp$1,405,069
- David A Schofield$6,507,079
Others in their field
Other Emerging Leaders on “Antibiotics”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
Research focus
AntibioticsAntimicrobial DrugAnti-Bacterial AgentsPseudomonas AeruginosaPathogenCellsInfectionEngineeringBacteriophagesPathogenic BacteriaTechnologyAntibiotic ResistanceResistanceBaseAntimicrobialBacteriaBacterial InfectionsCharacteristicsAntibiotic SusceptibilityCommunity-Acquired UtiAntimicrobial SusceptibilityBladder DiseasesCessation Of LifeCost
Grant awards (4)
Optimized methods for isolation and characterization of bacteriophage by VT-FACS$217,898
R21 · FY2021 · AI · contact PI
Rapid multiplex method for direct phenotypic ID/AST of bacterial pathogens$1,168,045
R01 · FY2020 · AI · contact PI
Rapid multiplex method for direct phenotypic ID/AST of bacterial pathogens$1,203,777
R01 · FY2019 · AI · contact PI
ANTI-TUBERCULOSIS ANTIBIOTIC QUANTIFICATION$299,999
N43 · FY2019 · AI · contact PI